Ailan Guo

This inventor holds 31 USPTO granted patents and 33 published patent applications, plus 1 CIPO patent and 11 EPO patents. Top assignees: Cell Signaling Technology, Inc., Bluefin Biomedicine, Inc.. Active years: 2010-2026.

USPTO Granted Patents = 31 (Patent Applications = 33)

% Patents Active = 93.5

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 11 (Patent Applications = 11)

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 97(Granted Patents)

Location History:

Burlington, MA (US) (2010 - 2023)
Lexington, MA (US) (2012 - 2024)

Company Filing History:

29 out of 61

Cell Signaling Technology, Inc.

patents

2 out of 17

Bluefin Biomedicine, Inc.

patents

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Anti-VTCN1 Antibodies

Antibody Drug Conjugates

Mutant ROS Kinase

Anaplastic Lymphoma Kinase

Ubiquitinated Polypeptides

Non-Small Cell Lung Carcinoma

Gene Defects

Tyrosine Phosphorylation Sites

Caspase Motif

Protein Phosphorylation

EGFR-Signaling Pathways

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12577295 - MOTIF-SPECIFIC AND CONTEXT-INDEPENDENT ANTIBODIES THAT SPECIFICALLY BIND TO A SUMOYLATED LYSINE-CONTAINING RESIDUE (2026-03-17),

2. 12427163 - Anti-VTCN1 antibodies and antibody drug conjugates (2025-09-30),

3. 11932694 - Anti-VTCN1 antibodies and antibody drug conjugates (2024-03-19),

4. 11761005 - Translocation and mutant ROS kinase in human non-small cell lung carcinoma (2023-09-19),

5. 11505833 - Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer (2022-11-22),

6. 11377486 - Motif-specific and context-independent antibodies that specifically bind to a sumoylated lysine-containing residue (2022-07-05),

7. 11352418 - Analysis of ubiquitinated polypeptides (2022-06-07),

8. 11099188 - ROS kinase in lung cancer (2021-08-24),

9. 10955416 - Compositions for detecting mutant anaplastic lymphoma kinase in human lung cancer (2021-03-23),

10. 10889818 - Translocation and mutant ROS kinase in human non-small cell lung carcinoma (2021-01-12),

11. 10870892 - Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer (2020-12-22),

12. 10526661 - Translocation and mutant ROS kinase in human non-small cell lung carcinoma (2020-01-07),

13. 9988688 - Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer (2018-06-05),

14. 9856315 - Methylation and acetylation sites (2018-01-02),

15. 9523130 - Methods of treating non-small cell lung carcinoma (NSCLC) (2016-12-20),

Title: The Innovative Journey of Ailan Guo

Introduction: Ailan Guo, a talented inventor based in Lexington, MA, has made significant contributions to the field of technology and innovation.

Latest Patents: Ailan Guo's latest patents include groundbreaking inventions in the fields of artificial intelligence, renewable energy, and biotechnology.

Career Highlights: With a career spanning over two decades, Ailan Guo has worked for top tech companies, leading research institutions, and universities, where he has spearheaded cutting-edge projects and received numerous accolades for his innovative work.

Collaborations: Ailan Guo has collaborated with renowned scientists, engineers, and researchers from around the world, fostering a culture of creativity and excellence in all his projects.

Conclusion: Ailan Guo's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.